The Latin America In Vitro Diagnostics (IVD) Market is expected to grow at a CAGR of 7.8% during the forecast period 2022–2029 to reach $7.75 billion by 2029. The burden of communicable and non-communicable diseases, rise in medical tourism, shift towards decentralized testing, and growing awareness regarding early disease diagnosis are driving the growth of this market.
In addition, inclination towards personalized healthcare and advances in genomics and proteomics offer opportunities for the IVD market. However, the regulatory scenarios in LATAM countries are posing a challenge to the growth of this market.
COVID-19 Impact Assessment
The COVID-19 pandemic had a devastating impact on Latin America. It had largely affected the Latin American economy in three ways:
All Latin American countries were highly affected by COVID-19 disease. Brazil was the second most affected country globally due to COVID-19, with the number of cases reaching 30,791,220 by May 2022. Brazil (665,680), Mexico (324,895), Peru (213,106), Colombia (139,833), and Argentina (128,776) had the region's highest numbers of deaths (Source: Worldometers). The rising burden of COVID-19 disease increased the demand for diagnostic products.
Also, the pandemic had seriously challenged health systems in the region. Countries developed different coping strategies such as increased manufacturing of diagnostics products, expansion of hospital and nursing facilities, investment in diagnostic and treatment options, and the issue of emergency use approval for various diagnostic kits. For instance, in July 2020, Ecuador deployed new sanitary mobile centers to expand testing for COVID-19 disease. In May 2020, the World Bank approved an emergency loan of $20 million to support the Uruguayan government in improving its testing capacity, early detection, and treatment of positive cases of COVID-19 disease.
Thus, the COVID-19 pandemic resulted in the expansion of the diagnostics market in this region.
-Market.png)
Click here to: Get Free Sample Copy of this report
The inclination toward Personalized Healthcare or Personalized Medicine is Propelling the Growth of Latin America In Vitro Diagnostics Market
Diagnosis is crucial for precision medicine to screen patients for breakthrough therapies and detect certain conditions such as cancer at an earlier stage. Personalized medicines for infectious diseases help orient the molecular management of infections.
The Personalized Health Index is a first-of-its-kind, data-driven policy tool that measures each country's progress toward the personalized future of healthcare. Uruguay held the first position in the Personalized Health Index for Latin America. Also, Mexico is one of the top five Latin American countries with the best conditions to integrate and promote personalized medicine, according to the Latin American Personalized Medicine Index.
Latin America performs best in personalized technologies such as devices, applications, and reimbursement structures that help drive personalized healthcare in the region. The countries in Latin America are progressing toward the adoption of personalized healthcare and medicine, providing opportunities for the IVD market in the region.
Growing Prevalence of Chronic and Infectious Diseases in the Region
Chronic infectious diseases caused by bacterial and viral pathogens are rising in Latin American countries due to various factors, including changes in climatic conditions, increased human population growth & density in urban & rural areas, increased human migration & mobility, and poor public health resources. The pathogenic agents that cause emerging and re-emerging diseases in Latin America include bacterial pathogens (Salmonella enteritidis, Salmonella typhimurium, Salmonella typhi, Brucellaabortus, and Klebsiella pneumonia) and viral pathogens (HPV, HIV, EBV, Zika, and Chikungunya).
According to UNAIDS, the number of adults and children living with HIV in the Latin American region had reached 2,100,000 in 2020 from 2,000,000 in 2018. The number of annual new infections has continued to rise in the region. Furthermore, the outbreak of COVID-19 disease had affected a large population in the region and spread continuously throughout the region. Apart from infectious diseases, non-communicable diseases (NCDs), including cancer, are the leading cause of preventable and premature deaths in Latin America. In 2020, cancer cases in Latin America were 1.47 million, which is estimated to reach 1.93 million by 2030 and 2.44 million by 2040 (Source: GLOBCAN)
This increase in the number of diseases in the region is fueling the growth of the Latin America IVD market.
Key Findings of the Latin America In Vitro Diagnostics Market Study:
Kits & Reagents Segment is Estimated to Grow at the Fastest CAGR during the Forecast Period
Factors such as the increasing prevalence of infectious diseases in the region and the increasing use of kits & reagents to identify the organism causing various diseases in less time and cost contribute to the high growth of this market. Furthermore, the outbreak of COVID-19 disease accelerated the growth of this segment due to the national emergency and the requirement of various kits & assays for early disease diagnosis.
Immunodiagnostics Segment is Expected to Grow at the Fastest CAGR during the Forecast Period
Rapid, convenient, and accurate research tools for the detection and quantification of targets, continuous development of new biomarkers, cost benefit, and growing adoption of automated platforms for ELISA are expected to increase the adoption of this segment.
Lab Testing Segment is Estimated to Dominate the Market in 2022
The lab testing approach for IVD has higher accuracy and reliability when compared to point of care testing. The laboratory equipment and analyzers have high sensitivity and specificity. The lab testing segment is expected to account for the largest share of the Latin America IVD market due to its higher accuracy and reliability, lower costs, availability of several IVD tests, and quality assurance program.
Hospital Labs are Estimated to Account for the Largest Share in 2022
Hospital laboratories have the capabilities to increase economies of scale and maximize the usage of equipment and staff while not reducing the level of service. Due to this reason, hospital laboratories are one of the major customers for IVD in Latin America.
Brazil is Expected to Dominate the Latin American IVD Market
Factors such as well-established healthcare infrastructure, growing healthcare expenditure, rising demand for genetic testing, increasing awareness about the use of IVD products, and growing awareness for cancer screening are responsible for the growth of this segment.
Key Players
The report includes a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments in leading industry market players over the past four years. The key players operating in the IVD market in Latin America are F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Abbott Laboratories (U.S.), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Qiagen N.V. (Netherlands), Thermo Fisher Scientific Inc. (U.S.), Wama Diagnóstica (Brazil), and Wiener Laboratorios SAIC (Argentina).
Scope of the Report:
Latin America In Vitro Diagnostics Market, by Product & Service
Latin America In Vitro Diagnostics Market, by Technology
Other technologies comprise microscopy, hybridization, and loop-mediated amplification
Latin America In Vitro Diagnostics Market, by Application
Other applications comprise nephrology, toxicology, gastroenterology, neonatal, genetic, and neurological disorders.
Latin America In Vitro Diagnostics Market, by Diagnostic Approach
Latin America In Vitro Diagnostics Market, by Customer Type
Other customers comprise long-term care facilities, academic & research institutes, ambulatory care centers, and transfusion laboratories.
Latin America In Vitro Diagnostics Market, by Country/Region
Key questions answered in the report-
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-up Approach
2.3.1.2. Top-down Approach
2.3.1.3. Growth forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study
3. Executive Summary
4. Market Dynamics
4.1. Market Overview
4.2. Drivers
4.2.1. Rising Prevalence of Communicable and Non-communicable Diseases
4.2.2. Growing Awareness Regarding Early Disease Diagnosis
4.2.3. Adoption of Point of Care Testing
4.2.4. Expanding Medical Tourism in the Region
4.3. Opportunities
4.3.1. Inclination towards Personalized Healthcare or Personalized Medicine
4.3.2. Advances in Genomics and Proteomics
4.4. Challenges
4.4.1. Regulatory Scenario in Latin American Countries
4.5. COVID-19 Impact on Latin America In Vitro Diagnostics Market
5. Latin America In Vitro Diagnostics Market, by Product & Service
5.1. Introduction
5.2. Kits & Reagents
5.3. Instruments
5.4. Software & Services
6. Latin America In Vitro Diagnostics Market, by Technology
6.1. Introduction
6.2. Immunoassay
6.3. Whole Blood Glucose Monitoring
6.4. Molecular Diagnostics
6.5. Point of Care Diagnostics
6.6. Clinical Chemistry
6.7. Haematology
6.8. Coagulation & Haemostasis
6.9. Critical Care Diagnostics
6.10. Urinalysis
6.11. Other Technologies
7. Latin America In Vitro Diagnostics Market, by Application
7.1. Introduction
7.2. Infectious Diseases
7.3. Diabetes
7.4. Oncology
7.5. Endocrinology
7.6. Cardiology
7.7. Other Applications
8. Latin America In Vitro Diagnostics Market, by Diagnostic Approach
8.1. Introduction
8.2. Lab Testing
8.3. OTC/Self-testing
8.4. Point of Care Testing
9. Latin America In Vitro Diagnostics Market, by Customer Type
9.1. Introduction
9.2. Hospital Laboratories
9.3. Private Laboratories
9.4. Home Care/Self-testing
9.5. Government Bodies
9.6. Other Customer Types
10. Latin America In Vitro Diagnostics Market, by Country/Region
10.1. Introduction
10.2. Brazil
10.3. Mexico
10.4. Argentina
10.5. Colombia
10.6. Peru
10.7. Chile
10.8. Ecuador
10.9. Uruguay
10.10. Dominican Republic
10.11. Paraguay
10.12. Bolivia
10.13. Rest of Latin America
11. Competitive landscape
11.1. Introduction
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Market Share Analysis (2021)
12. Company Profiles
12.1. Abbott Laboratories
12.2. Becton, Dickinson and Company
12.3. bioMérieux SA
12.4. Danaher Corporation
12.5. F. Hoffman-la Roche Ltd.
12.6. Qiagen N.V.
12.7. Siemens Healthineers AG
12.8. Thermo Fisher Scientific Inc.
12.9. Wama Diagnóstica
12.10. Wiener Laboratorios SAIC
13. Appendix
13.1. Questionnaire
List of Tables
Table 1 Latin America In Vitro Diagnostics Market Drivers: Impact Analysis (2022–2029)
Table 2 Latin America: Number of New HIV Cases by Country (2019 VS 2020)
Table 3 Latin America: Medical Tourism Destinations
Table 4 Latin America: Medical Tourism Index and Rankings (2020–2021)
Table 5 Personalized Health Index: Latin America
Table 6 Coronavirus Cases, Deaths, and Related Tests in Latin America (Till May 2022)
Table 7 Health Measures Implemented in Response to the COVID-19 Crisis in Latin America (2020)
Table 8 Latin America In Vitro Diagnostics Market Size, by Product & Service,2020–2029 (USD Million)
Table 9 Latin America In Vitro Diagnostics Kits & Reagents Market Size, by Country/Region, 2020–2029 (USD Million)
Table 10 Latin America In Vitro Diagnostics Instruments Market Size, by Country/Region, 2020–2029 (USD Million)
Table 11 Latin America In Vitro Diagnostics Instruments Market Volume, by Country/Region, 2020–2029 (Hundred Units)
Table 12 Price of In Vitro Diagnostics Instruments in Latin America, 2021
Table 13 Latin America In Vitro Diagnostics Software & Services Market Size, by Country/Region, 2020–2029 (USD Million)
Table 14 Latin America In Vitro Diagnostics Market, by Technology, 2020–2029 (USD Million)
Table 15 Latin America Immunoassay Market Size, by Country/Region, 2020–2029 (USD Million)
Table 16 Latin America Whole Blood Glucose Monitoring Market Size, by Country/Region, 2020–2029 (USD Million)
Table 17 Latin America Molecular Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 18 Latin America Point of Care Diagnostics Market Size, by Country/Region,2020–2029 (USD Million)
Table 19 Latin America Clinical Chemistry Market Size, by Country/Region, 2020–2029 (USD Million)
Table 20 Latin America Haematology Market Size, by Country/Region, 2020–2029 (USD Million)
Table 21 Latin America Coagulation and Haemostasis Market Size, by Country/Region, 2020–2029 (USD Million)
Table 22 Critical Care Diagnostics Market Size, by Country/Region, 2020–2029 (USD Million)
Table 23 Latin America Urinalysis Market Size, by Country/Region, 2020–2029 (USD Million)
Table 24 Latin America other In Vitro Diagnostics Technologies Market Size, by Country/Region, 2020–2029 (USD Million)
Table 25 Latin America In Vitro Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 26 Covid-19 Cases & Mortalities in Latin America (As of May 2022)
Table 27 Latin America: Number of HIV Cases (Adults & Children), by Country ‘2019’ and ‘2020’
Table 28 Technologies and their Applications in Various Infectious Diseases
Table 29 Latin America In Vitro Diagnostics Market Size for infectious Diseases, by Country/Region, 2022–2029 (USD Million)
Table 30 Latin America: Diabetes Cases, by Country (2021 VS 2030)
Table 31 Latin America In Vitro Diagnostics Market Size for Diabetes, by Country/Region, 2022–2029 (USD Million)
Table 32 Latin America: Cancer Cases, by Country (2020 VS 2030)
Table 33 Latin America In Vitro Diagnostics Market Size for Oncology, by Country/Region, 2022–2029 (USD Million)
Table 34 Latin America In Vitro Diagnostics Market Size for Endocrinology, by Country/Region, 2022–2029 (USD Million)
Table 35 Latin America: Deaths due to Cardiovascular Diseases, by Country (2019)
Table 36 Latin America In Vitro Diagnostics Market Size for Cardiology, by Country/Region, 2022–2029 (USD Million)
Table 37 Latin America In Vitro Diagnostics Market Size for Other Applications, by Country/Region, 2022–2029 (USD Million)
Table 38 Latin America In Vitro Diagnostics Market Size, by Diagnostic Approach, 2020–2029 (USD Million)
Table 39 Latin America In Vitro Diagnostics Market Size for Lab Testing, by Country/Region, 2022–2029 (USD Million)
Table 40 Latin America In Vitro Diagnostics Market Size for OTC/Self-testing, by Country/Region, 2022–2029 (USD Million)
Table 41 Latin America In Vitro Diagnostics Market Size for Point of Care Testing, by Country/Region, 2022–2029 (USD Million)
Table 42 Latin America In Vitro Diagnostics Market Size, by Customer Type, 2020–2029 (USD Million)
Table 43 Top Ranking Hospitals in Latin America
Table 44 Latin America In Vitro Diagnostics Market Size for Hospital Laboratories, by Country/Region, 2022–2029 (USD Million)
Table 45 Latin America In Vitro Diagnostics Market Size for Private Laboratories, by Country/Region, 2022–2029 (USD Million)
Table 46 Latin America In Vitro Diagnostics Market Size for Home Care/Self-testing, by Country/Region, 2022–2029 (USD Million)
Table 47 Latin America: Healthcare Expenditure, by Country/Region (2019)
Table 48 Latin America In Vitro Diagnostics Market Size for Government Bodies, by Country/Region, 2022–2029 (USD Million)
Table 49 Latin America In Vitro Diagnostics Market Size for Other Customer Types, by Country/Region, 2022–2029 (USD Million)
Table 50 Latin America in Vitro Diagnostic Market, by Country/Region, 2020–2029 (USD Million)
Table 51 Latin America: In Vitro Diagnostics Market Size, by Product & Service, (2020–2029) (USD Million)
Table 52 Latin America: In Vitro Diagnostics Market Size, by Technology, (2020–2029) (USD Million)
Table 53 Latin America: In Vitro Diagnostics Market Size, by Application, (2020–2029) (USD Million)
Table 54 Latin America: In Vitro Diagnostics Market Size, by Customer Type, (2020–2029) (USD Million)
Table 55 Latin America: In Vitro Diagnostics Market Size, by Diagnostic Approach, (2020–2029) (USD Million)
Table 56 Testing Initiatives for COVID-19 in Brazil
Table 57 Brazil: Macroindicators
Table 58 Brazil: In Vitro Diagnostics Market Size, by Product & Service, (2020–2029) (USD Million)
Table 59 Brazil: In Vitro Diagnostics Market Size, by Technology, (2020–2029) (USD Million)
Table 60 Brazil: In Vitro Diagnostics Market Size, by Application, (2020–2029) (USD Million)
Table 61 Brazil: In Vitro Diagnostics Market Size, by Customer Type, (2020–2029) (USD Million)
Table 62 Brazil: In Vitro Diagnostics Market Size, by Diagnostic Approach, (2020–2029) (USD Million)
Table 63 Mexico: Some of the Serological Tests Approved by the National Institute and Reference “Dr. Manuel Martínez Báez” (Indre) against COVID-19
Table 64 Mexico: Macroindicators
Table 65 Mexico: In Vitro Diagnostics Market Size, by Product & Service, (2020–2029) (USD Million)
Table 66 Mexico: In Vitro Diagnostics Market Size, by Technology, (2020–2029) (USD Million)
Table 67 Mexico: In Vitro Diagnostics Market Size, by Application, (2020–2029) (USD Million)
Table 68 Mexico: In Vitro Diagnostics Market Size, by Customer Type, (2020–2029) (USD Million)
Table 69 Mexico: In Vitro Diagnostics Market Size, by Diagnostic Approach, (2020–2029) (USD Million)
Table 70 Argentina: Macroindicators
Table 71 Argentina: In Vitro Diagnostics Market Size, by Product & Service, (2020–2029) (USD Million)
Table 72 Argentina: In Vitro Diagnostics Market Size, by Technology, (2020–2029) (USD Million)
Table 73 Argentina: In Vitro Diagnostics Market Size, by Application, (2020–2029) (USD Million)
Table 74 Argentina: In Vitro Diagnostics Market Size, by Customer Type, (2020–2029) (USD Million)
Table 75 Argentina: In Vitro Diagnostics Market Size, by Diagnostic Approach, (2020–2029) (USD Million)
Table 76 Colombia: Macroindicators
Table 77 Colombia: In Vitro Diagnostics Market Size, by Product & Service, (2020–2029) (USD Million)
Table 78 Colombia: In Vitro Diagnostics Market Size, by Technology, (2020–2029) (USD Million)
Table 79 Colombia: In Vitro Diagnostics Market Size, by Application, (2020–2029) (USD Million)
Table 80 Colombia: In Vitro Diagnostics Market Size, by Customer Type, (2020–2029) (USD Million)
Table 81 Colombia: In Vitro Diagnostics Market Size, by Diagnostic Approach, (2020–2029) (USD Million)
Table 82 Peru: Macroindicators
Table 83 Peru: In Vitro Diagnostics Market Size, by Product & Service, (2020–2029) (USD Million)
Table 84 Peru: In Vitro Diagnostics Market Size, by Technology, (2020–2029) (USD Million)
Table 85 Peru: In Vitro Diagnostics Market Size, by Application, (2020–2029) (USD Million)
Table 86 Peru: In Vitro Diagnostics Market Size, by Customer Type, (2020–2029) (USD Million)
Table 87 Peru: In Vitro Diagnostics Market Size, by Diagnostic Approach, (2020–2029) (USD Million)
Table 88 Chile: Macroindicators
Table 89 Chile: In Vitro Diagnostics Market Size, by Product & Service, (2020–2029) (USD Million)
Table 90 Chile: In Vitro Diagnostics Market Size, by Technology, (2020–2029) (USD Million)
Table 91 Chile: In Vitro Diagnostics Market Size, by Application, (2020–2029) (USD Million)
Table 92 Chile: In Vitro Diagnostics Market Size, by Customer Type, (2020–2029) (USD Million)
Table 93 Chile: In Vitro Diagnostics Market Size, by Diagnostic Approach, (2020–2029) (USD Million)
Table 94 Ecuador: Macroindicators
Table 95 Ecuador: In Vitro Diagnostics Market Size, by Product & Service, 2020–2029 (USD Million)
Table 96 Ecuador: In Vitro Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 97 Ecuador: In Vitro Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 98 Ecuador: In Vitro Diagnostics Market Size, by Customer Type, 2020–2029 (USD Million)
Table 99 Ecuador: In Vitro Diagnostics Market Size, by Diagnostic Approach, 2020–2029 (USD Million)
Table 100 Uruguay: Macroindicators
Table 101 Uruguay: In Vitro Diagnostics Market Size, by Product & Service, 2020–2029 (USD Million)
Table 102 Uruguay: In Vitro Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 103 Uruguay: In Vitro Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 104 Uruguay: In Vitro Diagnostics Market Size, by Customer Type, 2020–2029 (USD Million)
Table 105 Uruguay: In Vitro Diagnostics Market Size, by Diagnostic Approach, 2020–2029 (USD Million)
Table 106 Dominican Republic: Macroindicators
Table 107 Dominican Republic: In Vitro Diagnostics Market Size, by Product & Service, 2020–2029 (USD Million)
Table 108 Dominican Republic: In Vitro Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 109 Dominican Republic: In Vitro Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 110 Dominican Republic: In Vitro Diagnostics Market Size, by CustomerType,2020–2029 (USD Million)
Table 111 Dominican Republic: In Vitro Diagnostics Market Size, by Diagnostic Approach, 2020–2029 (USD Million)
Table 112 Paraguay: Macroindicators
Table 113 Paraguay: In Vitro Diagnostics Market Size, by Product & Service, 2020–2029 (USD Million)
Table 114 Paraguay: In Vitro Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 115 Paraguay: In Vitro Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 116 Paraguay: In Vitro Diagnostics Market Size, by Customer Type, 2020–2029 (USD Million)
Table 117 Paraguay: In Vitro Diagnostics Market Size, by Diagnostic Approach, 2020–2029 (USD Million)
Table 118 Bolivia: Top 5 Causes of Deaths (2020)
Table 119 Bolivia: Macroindicators
Table 120 Bolivia: In Vitro Diagnostics Market Size, by Product & Service, 2020–2029 (USD Million)
Table 121 Bolivia: In Vitro Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 122 Bolivia: In Vitro Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 123 Bolivia: In Vitro Diagnostics Market Size, by Customer Type, 2020–2029 (USD Million)
Table 124 Bolivia: In Vitro Diagnostics Market Size, by Diagnostic Approach, 2020–2029 (USD Million)
Table 125 Rest of Latin America: Macroindicators
Table 126 Rest of Latin America: In Vitro Diagnostics Market Size, by Product & Service, 2020–2029 (USD Million)
Table 127 Rest of Latin America: In Vitro Diagnostics Market Size, by Technology, 2020–2029 (USD Million)
Table 128 Rest of Latin America: In Vitro Diagnostics Market Size, by Application, 2020–2029 (USD Million)
Table 129 Rest of Latin America: In Vitro Diagnostics Market Size, by Customer Type, 2020–2029 (USD Million)
Table 130 Rest of Latin America: In Vitro Diagnostics Market Size, by Diagnostic Approach, 2020–2029 (USD Million)
Table 131 Recent Developments, by Company, 2019–2022
Table 132 Abbott Laboratories in Latin America
Table 133 Becton, Dickinson and Company (BD): Subsidiaries in Latin America
Table 134 F. Hoffmann-La Roche Ltd: Subsidiaries and Associates in Latin America
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Size Estimation
Figure 7 Latin America In Vitro Diagnostics Market Size, by Product & Service, 2022 VS 2029 (USD Million)
Figure 8 Latin America In Vitro Diagnostics Market Size, by Technology, 2022 VS 2029 (USD Million)
Figure 9 Latin America In Vitro Diagnostics Market Size, by Application, 2022 VS 2029 (USD Million)
Figure 10 Latin America In Vitro Diagnostics Market Size, by Customer Type, 2022 VS 2029 (USD Million)
Figure 11 Latin America In Vitro Diagnostics Market Size, by Country/Region
Figure 12 Market Dynamics
Figure 13 Latin America In Vitro Diagnostics Market Size, by Product & Service, 2022–2029 (USD Million)
Figure 14 Latin America In Vitro Diagnostics Market, by Technology, 2022 VS 2029 (USD Million)
Figure 15 Adult Population (20–79 Years) with Diabetes in Latin American Countries (Millions) (2021)
Figure 16 Latin America In Vitro Diagnostics Market Size, by Application, 2022–2029 (USD Million)
Figure 17 Diabetes Prevalence in the South and Central America Region
Figure 18 Latin America: Estimated Number of New Cancer Cases (2020–2040)
Figure 19 Latin America In Vitro Diagnostics Market Size, by Diagnostic Approach, 2022–2029 (USD Million)
Figure 20 Benefits of Lab Testing Approach
Figure 21 Benefits of Point of Care Testing Approach
Figure 22 Latin America In Vitro Diagnostics Market Size, by Customer Type, 2022–2029 (USD Million)
Figure 23 Latin America In Vitro Diagnostics Market: Snapshot
Figure 24 Brazil: Challenges to the In Vitro Diagnostics Market
Figure 25 Key Growth Strategies Adopted by Leading Players, 2019–2022
Figure 26 Latin America In Vitro Diagnostics Market: Competitive Benchmarking
Figure 27 Market Share Analysis: Latin America In Vitro Diagnostics Industry, 2021
Figure 28 Abbott Laboratories: Financial Overview, (2021)
Figure 29 Becton, Dickinson and Company: Financial Overview, (2021)
Figure 30 bioMérieux SA: Financial Overview, (2021)
Figure 31 Danaher Corporation: Financial Overview, (2021)
Figure 32 F. Hoffman-La Roche Ltd.: Financial Overview, (2021)
Figure 33 Qiagen N.V.: Financial Overview, (2021)
Figure 34 Siemens Healthineers AG: Financial Overview (2021)
Figure 35 Thermo Fisher Scientific Inc.: Financial Overview, (2021)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Nov-2022
Published Date: Oct-2022
Published Date: Oct-2022
Published Date: Oct-2022
